Cargando…
Estimating Patient-Specific Relative Benefit of Adding Biologics to Conventional Rheumatoid Arthritis Treatment: An Individual Participant Data Meta-Analysis
IMPORTANCE: Current evidence remains ambiguous regarding whether biologics should be added to conventional treatment of rheumatoid arthritis for specific patients, which may cause potential overuse or treatment delay. OBJECTIVES: To estimate the benefit of adding biologics to conventional antirheuma...
Autores principales: | Luo, Yan, Chalkou, Konstantina, Funada, Satoshi, Salanti, Georgia, Furukawa, Toshi A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314313/ https://www.ncbi.nlm.nih.gov/pubmed/37389866 http://dx.doi.org/10.1001/jamanetworkopen.2023.21398 |
Ejemplares similares
-
Predicting the treatment response of certolizumab for individual adult patients with rheumatoid arthritis: protocol for an individual participant data meta-analysis
por: Luo, Yan, et al.
Publicado: (2020) -
Decision Curve Analysis for Personalized Treatment Choice between
Multiple Options
por: Chalkou, Konstantina, et al.
Publicado: (2022) -
A two‐stage prediction model for heterogeneous effects of treatments
por: Chalkou, Konstantina, et al.
Publicado: (2021) -
Estimating and visualising the trade-off between benefits and harms on multiple clinical outcomes in network meta-analysis
por: Chiocchia, Virginia, et al.
Publicado: (2023) -
Global Trends in Highly Cited Studies in COVID-19 Research
por: Funada, Satoshi, et al.
Publicado: (2023)